BioCorRx Inc. Selling, General and Administrative Expense
BioCorRx Inc. (BICX) reported Selling, General and Administrative Expense of $686.32 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- BioCorRx Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $686.32K, a 43.90% decline year-over-year.
- BioCorRx Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $775.45K, a 12.49% decline year-over-year.
- BioCorRx Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $539.37K, a 35.73% decline year-over-year.
- BioCorRx Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.15M, a 3.98% decline year-over-year.
- BioCorRx Inc. selling, general and administrative expense for fiscal 2025 was $3.79M, a 5.03% increase from fiscal 2024.
- BioCorRx Inc. selling, general and administrative expense for fiscal 2024 was $3.61M, a 25.65% increase from fiscal 2023.
- BioCorRx Inc. selling, general and administrative expense for fiscal 2023 was $2.88M, a 15.68% decline from fiscal 2022.
- BioCorRx Inc. selling, general and administrative expense for fiscal 2022 was $3.41M, a 8.85% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $686.32K 10-Q · filed 2026-08-14 | $1.48M 10-Q · filed 2026-08-14 | $2.00M derived: sum of 3 quarters · filed 2026-08-14 | $3.15M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $775.45K 10-Q · filed 2026-05-15 | $1.31M derived: sum of 2 quarters · filed 2026-05-15 | $2.46M derived: sum of 3 quarters · filed 2026-05-15 | $3.68M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $539.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.68M derived: sum of 2 quarters · filed 2026-03-31 | $2.91M derived: sum of 3 quarters · filed 2026-08-14 | $3.79M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.15M 10-Q · filed 2025-11-14 | $2.37M derived: sum of 2 quarters · filed 2026-08-14 | $3.25M 10-Q · filed 2025-11-14 | $4.09M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.22M 10-Q · filed 2026-08-14 | $2.11M 10-Q · filed 2026-08-14 | $2.95M derived: sum of 3 quarters · filed 2026-08-14 | $4.14M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $886.08K 10-Q · filed 2026-05-15 | $1.73M derived: sum of 2 quarters · filed 2026-05-15 | $2.92M derived: sum of 3 quarters · filed 2026-05-15 | $3.75M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $839.19K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.03M derived: sum of 2 quarters · filed 2026-03-31 | $2.86M derived: sum of 3 quarters · filed 2026-03-31 | $3.61M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.19M 10-Q · filed 2025-11-14 | $2.02M derived: sum of 2 quarters · filed 2025-11-14 | $2.77M 10-Q · filed 2025-11-14 | $3.47M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $830.32K 10-Q · filed 2025-08-14 | $1.58M 10-Q · filed 2025-08-14 | $2.27M derived: sum of 3 quarters · filed 2025-08-14 | $2.95M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $750.10K 10-Q · filed 2025-05-15 | $1.44M derived: sum of 2 quarters · filed 2025-05-15 | $2.12M derived: sum of 3 quarters · filed 2025-05-15 | $2.83M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $693.59K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.37M derived: sum of 2 quarters · filed 2025-03-31 | $2.08M derived: sum of 3 quarters · filed 2025-03-31 | $2.88M 10-K · filed 2025-03-31 |
| 2023-09-30 | $674.46K 10-Q · filed 2024-11-14 | $1.39M derived: sum of 2 quarters · filed 2024-11-14 | $2.18M 10-Q · filed 2024-11-14 | $2.90M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $711.03K 10-Q · filed 2024-08-13 | $1.51M 10-Q · filed 2024-08-13 | $2.22M derived: sum of 3 quarters · filed 2024-08-13 | $3.00M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $796.05K 10-Q · filed 2024-05-15 | $1.51M derived: sum of 2 quarters · filed 2024-05-15 | $2.28M derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $717.08K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.49M derived: sum of 2 quarters · filed 2024-04-01 | $3.41M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $771.81K 10-Q · filed 2023-11-14 | $2.69M 10-Q · filed 2023-11-14 | ||
| 2021-12-31 | $3.74M 10-K · filed 2023-03-31 | |||
| 2012-03-31 | $113.89K 10-Q · filed 2012-07-10 | |||
| 2011-12-31 | $713.58K 10-K · filed 2012-05-18 | |||
| 2011-03-31 | $137.19K 10-Q · filed 2012-07-10 | |||
| 2010-12-31 | $119.95K 10-K · filed 2012-05-18 |